Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report

After the acute pandemic of coronavirus disease 2019 (COVID-19), a wide variety of symptoms are identified under the term post-COVID syndrome, such as persistent headache. Post-COVID headache can be presented in a broad spectrum like headache attributed to systemic infection, chronification of alrea...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pain research (Lausanne, Switzerland) Switzerland), 2022-04, Vol.3, p.858709
Main Authors: Özkan, Esra, Celebi, Özlem, Keskin, Özlem, Gursoy, Attila, Gürsoy-Özdemir, Yasemin
Format: Article
Language:English
Subjects:
antagonist
calcitonin gene-related peptide (CGRP)
migraine
Pain Research
post-COVID
SARS-CoV-2
spike protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73
cites cdi_FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73
container_end_page
container_issue
container_start_page 858709
container_title Frontiers in pain research (Lausanne, Switzerland)
container_volume 3
creator Özkan, Esra
Celebi, Özlem
Keskin, Özlem
Gursoy, Attila
Gürsoy-Özdemir, Yasemin
description After the acute pandemic of coronavirus disease 2019 (COVID-19), a wide variety of symptoms are identified under the term post-COVID syndrome, such as persistent headache. Post-COVID headache can be presented in a broad spectrum like headache attributed to systemic infection, chronification of already existing primary headache, or long-lasting, and also late-onset new daily persistent headache. Still, little is known about the pathophysiology of post-COVID headache, but activation of the trigeminovascular system may be one of the players. Here, we present a case with a severe, long-lasting post-COVID headache and its sudden cessation with calcitonin gene-related peptide (CGRP) monoclonal antibody treatment. In our previous protein mimicry study, we have pointed at mimicry of virus spike protein and CGRP receptors. This mechanism may enlighten the current, common, and yet unsolved post-COVID headache cases.
doi_str_mv 10.3389/fpain.2022.858709
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e4cfefa3887841ed977cf96a9c03b4a1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e4cfefa3887841ed977cf96a9c03b4a1</doaj_id><sourcerecordid>35434707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73</originalsourceid><addsrcrecordid>eNpVkdFu1DAQRSMEolXpB_CC_ANZ7NiOHR5AIYV2pUpdlarwZk3sya7LNo5sA-Jr-FWy3bZqn2Y01j1zx7co3jK64Fw374cJ_LioaFUttNSKNi-Kw6pWvJQ1-_HySX9QHKd0QymtNNVa8tfFAZeCC0XVYfFvmcgKY_Ip45jJKqRcdhfXyxNyhuDAbpC0KQXrIaMj333ekFUMGf1Y3leyHDNGsNmHMZHPmP8gjqQds--D85hIu56NpkyufYQt-Tb5n_jAIDA60p1ersglWpxyiJ8-kJZ0kHCeTCHmN8WrAbYJj-_rUXH19ctVd1aeX5wuu_a8tIJXuXTQNxyEbuqaIat755D2Cq1WYnBSWUEZq62WynEhJDIJFdOqcpJLLVDxo2K5x7oAN2aK_hbiXxPAm7tBiGsDMXu7RYPCDjgA11ppwdA1StmhqaGxlPcC2Mz6uGdNv_pbdHb-1_nwZ9DnL6PfmHX4bZrZJOM7M2wPsDGkFHF41DJqdtmbu-zNLnuzz37WvHu69FHxkDT_DwCFrfc</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report</title><source>PubMed Central</source><creator>Özkan, Esra ; Celebi, Özlem ; Keskin, Özlem ; Gursoy, Attila ; Gürsoy-Özdemir, Yasemin</creator><creatorcontrib>Özkan, Esra ; Celebi, Özlem ; Keskin, Özlem ; Gursoy, Attila ; Gürsoy-Özdemir, Yasemin</creatorcontrib><description>After the acute pandemic of coronavirus disease 2019 (COVID-19), a wide variety of symptoms are identified under the term post-COVID syndrome, such as persistent headache. Post-COVID headache can be presented in a broad spectrum like headache attributed to systemic infection, chronification of already existing primary headache, or long-lasting, and also late-onset new daily persistent headache. Still, little is known about the pathophysiology of post-COVID headache, but activation of the trigeminovascular system may be one of the players. Here, we present a case with a severe, long-lasting post-COVID headache and its sudden cessation with calcitonin gene-related peptide (CGRP) monoclonal antibody treatment. In our previous protein mimicry study, we have pointed at mimicry of virus spike protein and CGRP receptors. This mechanism may enlighten the current, common, and yet unsolved post-COVID headache cases.</description><identifier>ISSN: 2673-561X</identifier><identifier>EISSN: 2673-561X</identifier><identifier>DOI: 10.3389/fpain.2022.858709</identifier><identifier>PMID: 35434707</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>antagonist ; calcitonin gene-related peptide (CGRP) ; migraine ; Pain Research ; post-COVID ; SARS-CoV-2 ; spike protein</subject><ispartof>Frontiers in pain research (Lausanne, Switzerland), 2022-04, Vol.3, p.858709</ispartof><rights>Copyright © 2022 Özkan, Celebi, Keskin, Gursoy and Gürsoy-Özdemir.</rights><rights>Copyright © 2022 Özkan, Celebi, Keskin, Gursoy and Gürsoy-Özdemir. 2022 Özkan, Celebi, Keskin, Gursoy and Gürsoy-Özdemir</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73</citedby><cites>FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011137/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011137/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35434707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özkan, Esra</creatorcontrib><creatorcontrib>Celebi, Özlem</creatorcontrib><creatorcontrib>Keskin, Özlem</creatorcontrib><creatorcontrib>Gursoy, Attila</creatorcontrib><creatorcontrib>Gürsoy-Özdemir, Yasemin</creatorcontrib><title>Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report</title><title>Frontiers in pain research (Lausanne, Switzerland)</title><addtitle>Front Pain Res (Lausanne)</addtitle><description>After the acute pandemic of coronavirus disease 2019 (COVID-19), a wide variety of symptoms are identified under the term post-COVID syndrome, such as persistent headache. Post-COVID headache can be presented in a broad spectrum like headache attributed to systemic infection, chronification of already existing primary headache, or long-lasting, and also late-onset new daily persistent headache. Still, little is known about the pathophysiology of post-COVID headache, but activation of the trigeminovascular system may be one of the players. Here, we present a case with a severe, long-lasting post-COVID headache and its sudden cessation with calcitonin gene-related peptide (CGRP) monoclonal antibody treatment. In our previous protein mimicry study, we have pointed at mimicry of virus spike protein and CGRP receptors. This mechanism may enlighten the current, common, and yet unsolved post-COVID headache cases.</description><subject>antagonist</subject><subject>calcitonin gene-related peptide (CGRP)</subject><subject>migraine</subject><subject>Pain Research</subject><subject>post-COVID</subject><subject>SARS-CoV-2</subject><subject>spike protein</subject><issn>2673-561X</issn><issn>2673-561X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkdFu1DAQRSMEolXpB_CC_ANZ7NiOHR5AIYV2pUpdlarwZk3sya7LNo5sA-Jr-FWy3bZqn2Y01j1zx7co3jK64Fw374cJ_LioaFUttNSKNi-Kw6pWvJQ1-_HySX9QHKd0QymtNNVa8tfFAZeCC0XVYfFvmcgKY_Ip45jJKqRcdhfXyxNyhuDAbpC0KQXrIaMj333ekFUMGf1Y3leyHDNGsNmHMZHPmP8gjqQds--D85hIu56NpkyufYQt-Tb5n_jAIDA60p1ersglWpxyiJ8-kJZ0kHCeTCHmN8WrAbYJj-_rUXH19ctVd1aeX5wuu_a8tIJXuXTQNxyEbuqaIat755D2Cq1WYnBSWUEZq62WynEhJDIJFdOqcpJLLVDxo2K5x7oAN2aK_hbiXxPAm7tBiGsDMXu7RYPCDjgA11ppwdA1StmhqaGxlPcC2Mz6uGdNv_pbdHb-1_nwZ9DnL6PfmHX4bZrZJOM7M2wPsDGkFHF41DJqdtmbu-zNLnuzz37WvHu69FHxkDT_DwCFrfc</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Özkan, Esra</creator><creator>Celebi, Özlem</creator><creator>Keskin, Özlem</creator><creator>Gursoy, Attila</creator><creator>Gürsoy-Özdemir, Yasemin</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220401</creationdate><title>Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report</title><author>Özkan, Esra ; Celebi, Özlem ; Keskin, Özlem ; Gursoy, Attila ; Gürsoy-Özdemir, Yasemin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>antagonist</topic><topic>calcitonin gene-related peptide (CGRP)</topic><topic>migraine</topic><topic>Pain Research</topic><topic>post-COVID</topic><topic>SARS-CoV-2</topic><topic>spike protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özkan, Esra</creatorcontrib><creatorcontrib>Celebi, Özlem</creatorcontrib><creatorcontrib>Keskin, Özlem</creatorcontrib><creatorcontrib>Gursoy, Attila</creatorcontrib><creatorcontrib>Gürsoy-Özdemir, Yasemin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in pain research (Lausanne, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özkan, Esra</au><au>Celebi, Özlem</au><au>Keskin, Özlem</au><au>Gursoy, Attila</au><au>Gürsoy-Özdemir, Yasemin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report</atitle><jtitle>Frontiers in pain research (Lausanne, Switzerland)</jtitle><addtitle>Front Pain Res (Lausanne)</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>3</volume><spage>858709</spage><pages>858709-</pages><issn>2673-561X</issn><eissn>2673-561X</eissn><abstract>After the acute pandemic of coronavirus disease 2019 (COVID-19), a wide variety of symptoms are identified under the term post-COVID syndrome, such as persistent headache. Post-COVID headache can be presented in a broad spectrum like headache attributed to systemic infection, chronification of already existing primary headache, or long-lasting, and also late-onset new daily persistent headache. Still, little is known about the pathophysiology of post-COVID headache, but activation of the trigeminovascular system may be one of the players. Here, we present a case with a severe, long-lasting post-COVID headache and its sudden cessation with calcitonin gene-related peptide (CGRP) monoclonal antibody treatment. In our previous protein mimicry study, we have pointed at mimicry of virus spike protein and CGRP receptors. This mechanism may enlighten the current, common, and yet unsolved post-COVID headache cases.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35434707</pmid><doi>10.3389/fpain.2022.858709</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2673-561X
ispartof Frontiers in pain research (Lausanne, Switzerland), 2022-04, Vol.3, p.858709
issn 2673-561X
2673-561X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e4cfefa3887841ed977cf96a9c03b4a1
source PubMed Central
subjects antagonist
calcitonin gene-related peptide (CGRP)
migraine
Pain Research
post-COVID
SARS-CoV-2
spike protein
title Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A32%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20Persistent%20Post-COVID%20Headache%20Associated%20With%20Protein-Protein%20Interactions%20Between%20Antibodies%20Against%20Viral%20Spike%20Protein%20and%20CGRP%20Receptor?:%20A%20Case%20Report&rft.jtitle=Frontiers%20in%20pain%20research%20(Lausanne,%20Switzerland)&rft.au=%C3%96zkan,%20Esra&rft.date=2022-04-01&rft.volume=3&rft.spage=858709&rft.pages=858709-&rft.issn=2673-561X&rft.eissn=2673-561X&rft_id=info:doi/10.3389/fpain.2022.858709&rft_dat=%3Cpubmed_doaj_%3E35434707%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-dab93a489661e16bdde0b7ec874fd57c40116c857d3445e15a21872d53584e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/35434707&rfr_iscdi=true